key: cord-0775806-n4zoce09 authors: Li, Lei; Yu, Pengming; Yang, Mengxuan; Xie, Wei; Huang, Liyi; He, Chengqi; Gosselink, Rik; Quan, Wei; Jones, Alice Y M title: Physical Therapist Management of COVID-19 in the Intensive Care Unit: The West China Hospital Experience date: 2020-11-05 journal: Phys Ther DOI: 10.1093/ptj/pzaa198 sha: c05ce0057078d1bad6cdac00f2059579048a0f96 doc_id: 775806 cord_uid: n4zoce09 OBJECTIVE: Coronavirus disease 2019 (COVID-19) has dominated the attention of health care systems globally since January 2020. Various health disciplines including physical therapists are still exploring the best way to manage this new disease. The role and involvement of physical therapists in the management of COVID-19 are not yet well defined and are limited in many hospitals. This article reports a physical therapy service specially commissioned by the Health Commission of Sichuan Province to manage COVID-19 during patients’ stay in the intensive care unit (ICU) at the Public Health Clinical Center of Chengdu in China. METHODS: Patients diagnosed with COVID-19 were classified into 4 categories under a directive from the National Health Commission of the People’s Republic of China. Patients in the “severe” and “critical” categories were admitted to the ICU irrespective whether mechanical ventilation was required. Between January 31, 2020, and March 8, 2020, a cohort of 16 patients was admitted to the ICU at the Public Health Clinical Center of Chengdu. The median (minimum to maximum) hospital and ICU stays for these patients were 27 (11–46) and 15 (6–38) days, respectively. Medical management included antiviral, immunoregulation and supportive treatment of associated comorbidities. Physical therapist interventions included body positioning, airway clearance techniques, oscillatory positive end-expiratory pressure, inspiratory muscle training, and mobility exercises. All patients had at least 1 comorbidity. Three of the 16 patients required mechanical ventilation and were excluded for outcome measures that required understanding of verbal instructions. In the remaining 13 patients, respiratory outcomes—including the Borg Dyspnea Scale, peak expiratory flow rate, Pao(2)/Fio(2) ratio, maximal inspiratory pressure, strength outcomes, Medical Research Council Sum Score, and functional outcomes (including the Physical Function in Intensive Care Test score, De Morton Mobility Index, and Modified Barthel Index)—were measured on the first day the patient received the physical therapist intervention and at discharge. RESULTS: At discharge from the ICU, while most outcome measures were near normal for the majority of the patients, 61% and 31% of these patients had peak expiratory flow rate and maximal inspiratory pressure below 80% of the predicted value and 46% had De Morton Mobility Index values below the normative value. CONCLUSION: The respiratory and physical functions of some patients remained poor at ICU discharge, suggesting that long-term rehabilitation may be required for these patients. IMPACT: Our experience in the management of patients with COVID-19 has revealed that physical therapist intervention is safe and appears to be associated with an improvement in respiratory and physical function in patients with COVID-19 in the ICU. Results: At discharge from the ICU, while most outcome measures were near normal for the majority of the patients, 61% and 31% of these patients had peak expiratory flow rate and maximal inspiratory pressure below 80% of the predicted value and 46% had De Morton Mobility Index values below the normative value. The respiratory and physical functions of some patients remained poor at ICU discharge, suggesting that long-term rehabilitation may be required for these patients. Impact: Our experience in the management of patients with COVID-19 has revealed that physical therapist intervention is safe and appears to be associated with an improvement in respiratory and physical function in patients with COVID-19 in the ICU. In December 2019, a novel coronavirus was identified and named SARS-CoV-2, the seventh type of human coronavirus discovered. The pneumonia caused by this virus was subsequently named COVID-19. 1 Up to July 17, 2020, a total of 13,616,593 cases have been confirmed worldwide, with 585,727 deaths. 2 While antiviral and corticosteroids have been administered at different stages of COVID-19, 3 to date there is no effective vaccine and the COVID-19 pandemic is ongoing. In China, COVID-19 has been classified into 4 categories of severity: mild, general, severe and critical. 4 Common symptoms in mild cases include fever, fatigue and dry cough. Most of the severe and critical cases experience hypoxemia and/or dyspnea after 1 week, and some of these patients progress rapidly to acute respiratory distress syndrome, septic shock, progressive metabolic acidosis and coagulation disorders, leading to multiple organ failure. Current clinical therapy for these patients focuses primarily on symptomatic supportive therapy since there is limited effective medication to cure the infected and no vaccine eradicating COVID-19. Physical therapy is a recognized profession globally and the role of cardiorespiratory physical therapy in the management of acute and/or chronic respiratory conditions is well established. 5 The duration of hospital and ICU stays and the ventilation status are illustrated in Figure 1 . As COVID-19 is a new infectious disease, the role of rehabilitation in these patients was unclear, particularly in circumstances where there was a shortage of PPE. to all patients was adopted (see below). All of the patients who were breathing spontaneously were placed in an upright position for 20 minutes daily. Those who required heavy sedation or were in an The maximum inspiratory pressure (MIP) for each patient was measured and the percentage of the predicted value computed. 7 All patients were given a threshold inspiratory muscle training (IMT) device (Digi IMT S2; XEEX Co Ltd, Xiamen, China) and practiced a standardized IMT protocol (4 sets of 8 breaths at a designated intensity with 2-minute rests) 8 daily at a random allocation of either 30% or 50% MIP. Two training intensity levels were adopted because, prior to the COVID-19 pandemic, the physical therapist team had launched research to compare the effects of training intensity levels. While the original project had to be suspended, the rehabilitation 10 team considered it appropriate to randomly allocate patients with COVID-19 to 2 IMT intensity groups. The sequence of randomization followed the order of patient admission. That is, the first patient referred to physical therapy would receive 30% MIP as the training intensity, the next one would receive 50%, the third one would receive 30%, and so on. Patients on mechanical ventilation received a ventilator hyperinflation protocol 9 delivered by the physical therapists with assistance from respiratory therapists. The ventilator hyperinflation protocol consisted of the following: volume control breaths at an inspiratory flow of 20 L/min; tidal volume was increased by 200 mL per breath until the peak airway pressure reached 40 cm of H 2 O; 6 consecutive mechanical breaths were then delivered; and those 3 steps were repeated for 6 cycles. The aim of ventilator hyperinflation was to maintain and maximize lung recruitment. Deconditioning All 16 patients participated in a regimented sequence of mobility 10 : rolling over and moving on the bed regularly, sitting up in bed, sitting on the bedside, sitting on a chair, standing, and walking (along a 7-m walkway in the ICU). Only when each mobility stage was completed, was the next stage allowed. When physical therapists were off shift, nurses were encouraged to continue patient mobility activities by following the recommendation of the physical therapists. The frequency and mode of activities were prescribed by the physical therapist on the basis of patient assessments. During mobility exercises, oxygen saturation (SpO 2 ) stability (above 90%) and rate of perceived exertion (Modified Borg Dyspnea Scale) were constantly monitored. Patients were encouraged to rest if their rate of perceived exertion was 4 or above. [H1]Outcome Measures 13 De Morton Mobility Index (DEMMI), 14 Index. 15 Walking distance managed by the patient was also recorded. These data were available only from the 13 patients who were breathing spontaneously as these measurements cannot be undertaken when patients are mechanically ventilated. [H1]Patient Progression in the ICU [H2]Patients Who Were Spontaneously Breathing (n = 13) Thirteen of the 16 patients were breathing spontaneously on high-flow nasal oxygenation or nasal cannulae) (Fig. 1) . Ten patients produced a small amount of whitish sputum with the consistency of honey and 3 produced large amounts of intervention and at discharge from the ICU is illustrated in Table 3 , and group performance is displayed in Table 4 . Of these 13 patients, 11 were discharged to the isolation ward on or before March 8 and to home later. Two of them were discharged directly from the ICU to the nursing home from which they originated. All patients discharged from PHCCC had to exhibit at least 2 consecutive negative nucleic acid tests for SARS-CoV-2. about one-third of the patients still generated an MIP below 80% of the predicted value and 62% had PEFR below 80% of the predicted normal values. The low PEFR of our patient cohort at ICU discharge is of concern. A reduced PEFR is associated with poor airway clearance ability. 16 PEFR is correlated with peak cough rate in patients with chronic respiratory illness 17 and an effective cough is essential for Our patients participated in a vigorous mobilization routine based on the reported impact of severe acute respiratory syndrome on pulmonary and functional capacity in survivors of severe acute respiratory syndrome. 19 Pulmonary and functional impairments at 6 months after severe acute respiratory syndrome were comparable to those in patients after acute respiratory distress syndrome, 19 and an individual exercise program was shown to improve the aerobic and exercise capacity of survivors of severe acute respiratory syndrome. 20 To optimize the respiratory and functional This is a descriptive report and should be read in light of the following limitations. The number of patients is relatively small, and it was not ethical to have a ‗control' group for comparison. All patients in the severe and critical categories were seen by our physical therapists and therefore no inference can be properly drawn as to whether patient recovery was natural or facilitated by rehabilitative intervention. Second, rehabilitation therapy was initiated in the middle phase of the disease and we are therefore unsure whether the absence of respiratory and mobility interventions in the early period of this disease influence the therapeutic efficacy of later physical therapist interventions in these patients. Another limitation of our report is that we were unable to compare and reflect on the differences between our cohort of patients with COVID-19 and ICU cohorts with pneumonia or influenza. Twelve of our 16 patients in the current study were identified as ‗critical', but only 3 received mechanical ventilation. The majority of our patients did not demonstrate ICU acquired weakness, as illustrated by the high Medical Research Council Sum Score. This might be associated with our rigorous walking and battery of functional tasks applied, but also because these patients were not on mechanical ventilation and they were not sedated. However, the response of health care systems to the pandemic differs considerably in different countries, depending on the availability of human and equipment resources. To us, it is still a valuable lesson learned. [H1]Conclusion Our data support the pro-active implementation of physical therapy for patients with severe and critical illness caused by COVID-19 in maintaining airway clearance, and respiratory and functional capacity. Our data suggest that sputum retention and mobility was not a significant problem in the middle phase of the disease. However, U N C O R R E C T E D M A N U S C R I P T U N C O R R E C T E D M A N U S C R I P T U N C O R R E C T E D M A N U S C R I P TU N C O R R E C T E D M A N U S C R I P T Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study WHO situation reports Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7). In: National Health Commission of the People's Republic of China 2020 Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations Reference values for maximal inspiratory pressure: a systematic review Can inspiratory muscle training improve weaning outcomes in difficult to wean patients? A protocol for a randomised controlled trial (IMweanT study) A comparison of the effects of manual and ventilation hyperinflation on static lung compliance and sputum production in intubated and ventilated intensive care patients Physiotherapy in the intensive care unit Perceived exertion as an indicator of somatic stress Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit A physical function test for use in the intensive care unit: validity, responsiveness, and predictive utility of the Physical Function in ICU Test (scored) Reliability and validity of the German translation of the de Morton Mobility Index (DEMMI) performed by physiotherapists in patients admitted to a sub-acute inpatient geriatric rehabilitation hospital Improving the sensitivity of the Barthel Index for stroke rehabiliation Criteria for extubation and tracheostomy tube removal for patients with vetilatory failure: a different approach to weaning Correlation of peak cough rate with peak experiatory flow rate in patients with chronic respiratory diseases Respiratory pressures and expiratory peak flow rate of patients undergoing coronary artery bypass graft surgery Recovery pathway of post-SARS patients A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project The de Morton Mobility Index: normative data for a clinically useful mobility instrument COVID-19 and pulmonary rehabilitation: preparing for phase three Establishing essential cardiopulmonary physiotherapy services in acute care settings in China MIP = maximal inspiratory pressure; MRC-ss = daily Medical Research Council Sum Score PEFR = peak expiratory flow rate PFIT = Physical Function in Intensive Care Test The authors completed the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported no conflicts of interest.